Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trialOACSCD
Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty:a randomized controlled trial
Yi Ren;Shi-Liang Cao;Zeng Li;Tim Luo;Bin Feng;Xi-Sheng Weng
Department of Orthopedic Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Beijing 100730,ChinaDepartment of Orthopaedic Surgery,Peking University Third Hospital,Peking University,Beijing 100191,ChinaDepartment of Orthopedic Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Beijing 100730,ChinaDoctor of Medicine Program,University of Alberta,Edmonton,AB T6G 2R3,CanadaDepartment of Orthopedic Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Beijing 100730,ChinaDepartment of Orthopedic Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Beijing 100730,China
Total hip arthroplastyAspirinRivaroxabanVenous thromboembolismBlood lossComplication
Total hip arthroplastyAspirinRivaroxabanVenous thromboembolismBlood lossComplication
《中华医学杂志（英文版）》 2021 (2)
164-172,9
This work was supported by the National Nature Science Foundation in China(No.81871740).